vaccines

Cambridge spin-out DIOSynVax's pEVAC-PS, the first vaccine whose active ingredient was designed entirely by computer, proved safe in 39 volunteers but produced only modest immunity.

UK health officials are widening the MenB response in Kent by offering second doses to people already given a first shot, after an outbreak that has left two people dead and 21 confirmed cases.

Phase 3 PreVenTB trial of 12,717 people across India shows VPM1002 cuts extrapulmonary tuberculosis by 50%, but neither candidate prevents pulmonary TB or latent infection.

A study of nearly 250,000 U.S. adults finds the shingles vaccine dramatically reduces heart attacks, strokes, and deaths in people with existing cardiovascular disease.

A federal court has halted sweeping changes to the national childhood immunization schedule and frozen Kennedy's ACIP appointments, finding the reconstituted panel likely violated federal law.